[On vasculoprotective therapy in various hemorrhagic syndromes].
D000293:Adolescent; D000328:Adult; D000368:Aged; D001791:Blood Platelet Disorders / Q000188:drug therapy*; D002199:Capillary Permeability / Q000187:drug effects*; D002318:Cardiovascular Diseases / Q000188:drug therapy*; D002648:Child; D003374:Coumarins / Q000627:therapeutic use*; D003925:Diabetic Angiopathies / Q000188:drug therapy; D005776:Gaucher Disease / Q000188:drug therapy; D006111:Graves Disease / Q000188:drug therapy*; D006474:Hemorrhagic Disorders / Q000188:drug therapy*; D006689:Hodgkin Disease / Q000188:drug therapy*; D006801:Humans; D008107:Liver Diseases / Q000188:drug therapy*; D008875:Middle Aged; D011696:Purpura, Thrombocytopenic / Q000188:drug therapy*; D012213:Rheumatic Fever / Q000188:drug therapy; D012509:Sarcoma / Q000188:drug therapy
D003374:Coumarins
Sulla terapia vasculoprotettiva in alcune sindromi emorragiche.